A Systematic Approach to Explore the Rigor of Applied Behavioral Pharmacology Research
Saved in:
| Title: | A Systematic Approach to Explore the Rigor of Applied Behavioral Pharmacology Research |
|---|---|
| Language: | English |
| Authors: | Nazurah Khokhar (ORCID |
| Source: | Review Journal of Autism and Developmental Disorders. 2025 12(2):380-396. |
| Availability: | Springer. Available from: Springer Nature. One New York Plaza, Suite 4600, New York, NY 10004. Tel: 800-777-4643; Tel: 212-460-1500; Fax: 212-460-1700; e-mail: customerservice@springernature.com; Web site: https://link.springer.com/ |
| Peer Reviewed: | Y |
| Page Count: | 17 |
| Publication Date: | 2025 |
| Document Type: | Journal Articles Information Analyses |
| Descriptors: | Behavioral Science Research, Pharmacology, Behavior Problems, Intellectual Disability, Developmental Disabilities, Clinical Diagnosis, Intervention, Behavior Modification, Drug Therapy, Scores, Research Methodology, Barriers |
| DOI: | 10.1007/s40489-023-00400-7 |
| ISSN: | 2195-7177 2195-7185 |
| Abstract: | Applied behavioral pharmacology explores how drugs may influence problem behavior in persons with intellectual and developmental disability (IDD). A comprehensive review was conducted featuring single-case experimental designs in the domain of applied behavioral pharmacology to evaluate and report on study quality. Studies included in the review featured participants with a diagnosis of IDD, with problem behavior as the intervention target, and who were receiving psychotropic medications to address problem behavior. Fifty-five articles met criteria and were scored using a 20-item literature-informed Quality Indicator Checklist. Total checklist scores ranged between 32 and 81% which suggest room for improvement regarding the methodological rigor of research in this domain. Barriers and possible solutions to improving study quality are discussed. |
| Abstractor: | As Provided |
| Entry Date: | 2025 |
| Accession Number: | EJ1473364 |
| Database: | ERIC |
| Abstract: | Applied behavioral pharmacology explores how drugs may influence problem behavior in persons with intellectual and developmental disability (IDD). A comprehensive review was conducted featuring single-case experimental designs in the domain of applied behavioral pharmacology to evaluate and report on study quality. Studies included in the review featured participants with a diagnosis of IDD, with problem behavior as the intervention target, and who were receiving psychotropic medications to address problem behavior. Fifty-five articles met criteria and were scored using a 20-item literature-informed Quality Indicator Checklist. Total checklist scores ranged between 32 and 81% which suggest room for improvement regarding the methodological rigor of research in this domain. Barriers and possible solutions to improving study quality are discussed. |
|---|---|
| ISSN: | 2195-7177 2195-7185 |
| DOI: | 10.1007/s40489-023-00400-7 |
